| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Laboratory of Cellular Oncology, National Cancer Institute, and
Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892
The role of viral structural proteins in the initiation of adaptive
immune responses is poorly understood. To address this issue, we
focused on the effect of noninfectious papillomavirus-like particles
(VLPs) on dendritic cell (DC) activation. We found that murine bone
marrow-derived dendritic cells (BMDCs) effectively bound and rapidly
internalized bovine papillomavirus VLPs. Exposure to fully assembled
VLPs of bovine papillomavirus, human papillomavirus (HPV)16 or HPV18,
but not to predominately disordered HPV16 capsomers, induced acute
phenotypic maturation of BMDCs. Structurally similar polyomavirus VLPs
bound to the DC surface and were internalized, but failed to induce
maturation. DCs that had incorporated HPV16 VLPs produced
proinflammatory cytokines IL-6 and TNF-
; however, the release of
these cytokines was delayed relative to LPS activation. Production of
IL-12p70 by VLP-exposed DCs required the addition of syngeneic T cells
or rIFN-
. Finally, BMDCs pulsed with HPV16 VLPs induced
Th1-dominated primary T cell responses in vitro. Our data provide
evidence that DCs respond to intact papillomavirus capsids and that
they play a central role in VLP-induced immunity. These results offer a
mechanistic explanation for the striking ability of papillomavirus
VLP-based vaccines to induce potent T and B cell responses even in the
absence of adjuvant.
This article has been cited by other articles:
|
|
 |
|
  I Sutton, R Lahoria, I. Tan, P Clouston, and M. Barnett CNS demyelination and quadrivalent HPV vaccination Multiple Sclerosis, January 1, 2009; 15(1): 116 - 119. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Barth, E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, et al. Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells J. Virol., April 1, 2008; 82(7): 3466 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lacasse, J. Denis, R. Lapointe, D. Leclerc, and A. Lamarre Novel Plant Virus-Based Vaccine Induces Protective Cytotoxic T-Lymphocyte-Mediated Antiviral Immunity through Dendritic Cell Maturation J. Virol., January 15, 2008; 82(2): 785 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garcia-Pineres, A. Hildesheim, L. Dodd, T. J. Kemp, M. Williams, C. Harro, D. R. Lowy, J. T. Schiller, and L. A. Pinto Cytokine and Chemokine Profiles following Vaccination with Human Papillomavirus Type 16 L1 Virus-Like Particles Clin. Vaccine Immunol., August 1, 2007; 14(8): 984 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Da Silva, S. C. Fausch, J. S. Verbeek, and W. M. Kast Uptake of Human Papillomavirus Virus-Like Particles by Dendritic Cells Is Mediated by Fc{gamma} Receptors and Contributes to Acquisition of T Cell Immunity J. Immunol., June 15, 2007; 178(12): 7587 - 7597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Fakruddin, R. A. Lempicki, R. J. Gorelick, J. Yang, J. W. Adelsberger, A. J. Garcia-Pineres, L. A. Pinto, H. C. Lane, and T. Imamichi Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27 Blood, March 1, 2007; 109(5): 1841 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hervas-Stubbs, P. Rueda, L. Lopez, and C. Leclerc Insect Baculoviruses Strongly Potentiate Adaptive Immune Responses by Inducing Type I IFN J. Immunol., February 15, 2007; 178(4): 2361 - 2369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Buonaguro, M. L. Tornesello, M. Tagliamonte, R. C. Gallo, L. X. Wang, R. Kamin-Lewis, S. Abdelwahab, G. K. Lewis, and F. M. Buonaguro Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J. Virol., September 1, 2006; 80(18): 9134 - 9143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. S. Liu, J. Dyer, G. R. Leggatt, G. J. P. Fernando, J. Zhong, R. Thomas, and I. H. Frazer Overcoming Original Antigenic Sin to Generate New CD8 T Cell IFN-{gamma} Responses in an Antigen-Experienced Host. J. Immunol., September 1, 2006; 177(5): 2873 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Rollison, E. A. Engels, N. A. Halsey, K. V. Shah, R. P. Viscidi, and K. J. Helzlsouer Prediagnostic Circulating Antibodies to JC and BK Human Polyomaviruses and Risk of Non-Hodgkin Lymphoma. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 543 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Velupillai, R. L. Garcea, and T. L. Benjamin Polyoma Virus-Like Particles Elicit Polarized Cytokine Responses in APCs from Tumor-Susceptible and -Resistant Mice J. Immunol., January 15, 2006; 176(2): 1148 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yang, F. M. Murillo, M. J. Delannoy, R. L. Blosser, W. H. Yutzy IV, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. S. Roden B Lymphocyte Activation by Human Papillomavirus-Like Particles Directly Induces Ig Class Switch Recombination via TLR4-MyD88 J. Immunol., June 15, 2005; 174(12): 7912 - 7919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yang, C. M. Wheeler, X. Chen, S. Uematsu, K. Takeda, S. Akira, D. V. Pastrana, R. P. Viscidi, and R. B. S. Roden Papillomavirus Capsid Mutation To Escape Dendritic Cell-Dependent Innate Immunity in Cervical Cancer J. Virol., June 1, 2005; 79(11): 6741 - 6750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bousarghin, P. Hubert, E. Franzen, N. Jacobs, J. Boniver, and P. Delvenne Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells J. Gen. Virol., May 1, 2005; 86(5): 1297 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Barth, A. Ulsenheimer, G. R. Pape, H. M. Diepolder, M. Hoffmann, C. Neumann-Haefelin, R. Thimme, P. Henneke, R. Klein, G. Paranhos-Baccala, et al. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells Blood, May 1, 2005; 105(9): 3605 - 3614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Rochman, W. E. Paul, and S. Z. Ben-Sasson IL-6 Increases Primed Cell Expansion and Survival J. Immunol., April 15, 2005; 174(8): 4761 - 4767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Boisgerault, P. Rueda, C. M. Sun, S. Hervas-Stubbs, M. Rojas, and C. Leclerc Cross-Priming of T Cell Responses by Synthetic Microspheres Carrying a CD8+ T Cell Epitope Requires an Adjuvant Signal J. Immunol., March 15, 2005; 174(6): 3432 - 3439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pulendran Variegation of the Immune Response with Dendritic Cells and Pathogen Recognition Receptors J. Immunol., March 1, 2005; 174(5): 2457 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. J. Wong and R. F. Siliciano Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in Mice J. Virol., February 1, 2005; 79(3): 1701 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ruedl, K. Schwarz, A. Jegerlehner, T. Storni, V. Manolova, and M. F. Bachmann Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies J. Virol., January 15, 2005; 79(2): 717 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yang, F. M. Murillo, H. Cui, R. Blosser, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. S. Roden Papillomavirus-Like Particles Stimulate Murine Bone Marrow-Derived Dendritic Cells To Produce Alpha Interferon and Th1 Immune Responses via MyD88 J. Virol., October 15, 2004; 78(20): 11152 - 11160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, R. Fayad, X. Wang, D. Quinn, and L. Qiao Human Immunodeficiency Virus Type 1 Gag-Specific Mucosal Immunity after Oral Immunization with Papillomavirus Pseudoviruses Encoding Gag J. Virol., October 1, 2004; 78(19): 10249 - 10257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yang, F. M. Murillo, K.-Y. Lin, W. H. Yutzy IV, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. S. Roden Human Papillomavirus Type-16 Virus-Like Particles Activate Complementary Defense Responses in Key Dendritic Cell Subpopulations J. Immunol., August 15, 2004; 173(4): 2624 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yao, R. Zhang, L. Guo, M. Li, and C. Chen Th Cell-Independent Immune Responses to Chimeric Hemagglutinin/Simian Human Immunodeficiency Virus-Like Particles Vaccine J. Immunol., August 1, 2004; 173(3): 1951 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mandic and T. Vujkov Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? Ann. Onc., February 1, 2004; 15(2): 197 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Buck, D. V. Pastrana, D. R. Lowy, and J. T. Schiller Efficient Intracellular Assembly of Papillomaviral Vectors J. Virol., January 15, 2004; 78(2): 751 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Warfield, C. M. Bosio, B. C. Welcher, E. M. Deal, M. Mohamadzadeh, A. Schmaljohn, M. J. Aman, and S. Bavari Ebola virus-like particles protect from lethal Ebola virus infection PNAS, December 23, 2003; 100(26): 15889 - 15894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tsunetsugu-Yokota, Y. Morikawa, M. Isogai, A. Kawana-Tachikawa, T. Odawara, T. Nakamura, F. Grassi, B. Autran, and A. Iwamoto Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs J. Virol., October 1, 2003; 77(19): 10250 - 10259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Biemelt, U. Sonnewald, P. Galmbacher, L. Willmitzer, and M. Muller Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants J. Virol., September 1, 2003; 77(17): 9211 - 9220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Davidson, P. Sehr, R. L. Faulkner, J. L. Parish, K. Gaston, R. A. Moore, M. Pawlita, H. C. Kitchener, and P. L. Stern Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia J. Gen. Virol., August 1, 2003; 84(8): 2089 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ohlschlager, W. Osen, K. Dell, S. Faath, R. L. Garcea, I. Jochmus, M. Muller, M. Pawlita, K. Schafer, P. Sehr, et al. Human Papillomavirus Type 16 L1 Capsomeres Induce L1-Specific Cytotoxic T Lymphocytes and Tumor Regression in C57BL/6 Mice J. Virol., April 15, 2003; 77(8): 4635 - 4645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Viscidi, D. E. M. Rollison, E. Viscidi, B. Clayman, E. Rubalcaba, R. Daniel, E. O. Major, and K. V. Shah Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays Clin. Vaccine Immunol., March 1, 2003; 10(2): 278 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Shreedhar, B. L. Kelsall, and M. R. Neutra Cholera Toxin Induces Migration of Dendritic Cells from the Subepithelial Dome Region to T- and B-Cell Areas of Peyer's Patches Infect. Immun., January 1, 2003; 71(1): 504 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chackerian, P. Lenz, D. R. Lowy, and J. T. Schiller Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles J. Immunol., December 1, 2002; 169(11): 6120 - 6126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Balmelli, S. Demotz, H. Acha-Orbea, P. De Grandi, and D. Nardelli-Haefliger Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles J. Virol., November 13, 2002; 76(24): 12596 - 12602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Fausch, D. M. Da Silva, M. P. Rudolf, and W. M. Kast Human Papillomavirus Virus-Like Particles Do Not Activate Langerhans Cells: A Possible Immune Escape Mechanism Used by Human Papillomaviruses J. Immunol., September 15, 2002; 169(6): 3242 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Emeny, C. M. Wheeler, K. U. Jansen, W. C. Hunt, T.-M. Fu, J. F. Smith, S. MacMullen, M. T. Esser, and X. Paliard Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine J. Virol., June 27, 2002; 76(15): 7832 - 7842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Moron, P. Rueda, I. Casal, and C. Leclerc CD8{alpha}2 CD11b+ Dendritic Cells Present Exogenous Virus-like Particles to CD8+ T Cells and Subsequently Express CD8{alpha} and CD205 Molecules J. Exp. Med., May 20, 2002; 195(10): 1233 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Steele, S. Roberts, S. M. Rookes, and P. H. Gallimore Detection of CD4+- and CD8+-T-Cell Responses to Human Papillomavirus Type 1 Antigens Expressed at Various Stages of the Virus Life Cycle by Using an Enzyme-Linked Immunospot Assay of Gamma Interferon Release J. Virol., May 13, 2002; 76(12): 6027 - 6036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni, F. Lechner, I. Erdmann, T. Bachi, A. Jegerlehner, T. Dumrese, T. M. Kundig, C. Ruedl, and M. F. Bachmann Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles J. Immunol., March 15, 2002; 168(6): 2880 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Touze, L. Bousarghin, C. Ster, A.-L. Combita, P. Roingeard, and P. Coursaget Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells J. Gen. Virol., December 1, 2001; 82(12): 3005 - 3009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Clark, W. Caparros-Wanderley, G. Musselwhite, M. Kotecha, and B. E. Griffin Immunity against both polyomavirus VP1 and a transgene product induced following intranasal delivery of VP1 pseudocapsid-DNA complexes J. Gen. Virol., November 1, 2001; 82(11): 2791 - 2797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shi, J. Liu, Y. Huang, and L. Qiao Papillomavirus Pseudovirus: a Novel Vaccine To Induce Mucosal and Systemic Cytotoxic T-Lymphocyte Responses J. Virol., November 1, 2001; 75(21): 10139 - 10148. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
